Latest Insider Transactions at Ge Health Care Technologies Inc. (GEHC)
This section provides a real-time view of insider transactions for Ge Health Care Technologies Inc. (GEHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GE HealthCare Technologies Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GE HealthCare Technologies Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Betty D Larson Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,995
-9.27%
|
$1,000,545
$91.28 P/Share
|
|
Mar 01
2024
|
Jan Makela CEO, Imaging |
BUY
Grant, award, or other acquisition
|
Direct |
8,088
+11.32%
|
-
|
|
Mar 01
2024
|
Jan Makela CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
19,359
-7.17%
|
$1,761,669
$91.28 P/Share
|
|
Mar 01
2024
|
George A. Newcomb Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,078
+10.12%
|
-
|
|
Mar 01
2024
|
George A. Newcomb Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,532
-6.28%
|
$230,412
$91.28 P/Share
|
|
Mar 01
2024
|
Kevin Michael O'Neill CEO, PDx |
BUY
Grant, award, or other acquisition
|
Direct |
3,235
+11.87%
|
-
|
|
Mar 01
2024
|
Kevin Michael O'Neill CEO, PDx |
SELL
Payment of exercise price or tax liability
|
Direct |
8,225
-7.95%
|
$748,475
$91.28 P/Share
|
|
Feb 21
2024
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
14,950,000
-24.28%
|
-
|
|
Feb 02
2024
|
Taha Kass Hout Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,805
-11.41%
|
$577,570
$74.35 P/Share
|
|
Nov 01
2023
|
Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. |
SELL
Payment of exercise price or tax liability
|
Direct |
7,157
-11.93%
|
$479,519
$67.23 P/Share
|
|
Aug 03
2023
|
Jan Makela CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
4,596
-7.43%
|
$349,296
$76.19 P/Share
|
|
Aug 03
2023
|
Kevin Michael O'Neill CEO, PDx |
SELL
Payment of exercise price or tax liability
|
Direct |
1,532
-6.38%
|
$116,432
$76.19 P/Share
|
|
Aug 03
2023
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,630
-7.3%
|
$123,880
$76.19 P/Share
|
|
Jul 31
2023
|
Kevin Michael O'Neill CEO, PDx |
SELL
Open market or private sale
|
Direct |
15,609
-22.22%
|
$1,201,893
$77.01 P/Share
|
|
Jul 31
2023
|
Kevin Michael O'Neill CEO, PDx |
BUY
Exercise of conversion of derivative security
|
Direct |
13,275
+26.25%
|
$531,000
$40.4 P/Share
|
|
Jul 01
2023
|
Jan Makela CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,929
-3.02%
|
$154,320
$80.36 P/Share
|
|
Jun 23
2023
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
1,218,685
-1.94%
|
-
|
|
Jun 14
2023
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
2,531,315
-3.87%
|
-
|
|
Jun 12
2023
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
25,000,000
-27.68%
|
-
|
|
Jun 08
2023
|
Roland Rott CEO, Imaging |
SELL
Open market or private sale
|
Direct |
2,473
-9.97%
|
$190,421
$77.37 P/Share
|
|
Jun 01
2023
|
James Saccaro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,693
+25.46%
|
-
|
|
May 23
2023
|
Watkin Phoebe L. Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+50.0%
|
-
|
|
May 23
2023
|
Catherine A Lesjak Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+50.0%
|
-
|
|
May 23
2023
|
H Lawrence Culp Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+0.61%
|
-
|
|
May 23
2023
|
Anne T Madden Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,798
+35.1%
|
-
|
|
May 23
2023
|
Tomislav Mihaljevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+50.0%
|
-
|
|
May 23
2023
|
William J Stromberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,992
+36.0%
|
-
|
|
May 23
2023
|
Lloyd Howell Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+50.0%
|
-
|
|
May 23
2023
|
Risa J Lavizzo Mourey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+43.66%
|
-
|
|
May 23
2023
|
Rodney F Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,798
+35.1%
|
-
|
|
Apr 01
2023
|
Helmut Zodl Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,448
-6.11%
|
$282,736
$82.12 P/Share
|
|
Apr 01
2023
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-3.26%
|
$68,634
$82.12 P/Share
|
|
Mar 14
2023
|
Jan Makela CEO, Imaging |
SELL
Open market or private sale
|
Direct |
70,629
-28.25%
|
$5,438,433
$77.87 P/Share
|
|
Mar 14
2023
|
Jan Makela CEO, Imaging |
BUY
Exercise of conversion of derivative security
|
Direct |
64,945
+10.03%
|
$3,442,085
$53.33 P/Share
|
|
Mar 02
2023
|
Jan Makela CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,525
-2.15%
|
$114,375
$75.04 P/Share
|
|
Mar 02
2023
|
George A. Newcomb Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
437
-5.18%
|
$32,775
$75.04 P/Share
|
|
Mar 02
2023
|
Thomas J. Westrick CEO, Patient Care Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
565
-3.3%
|
$42,375
$75.04 P/Share
|
|
Mar 02
2023
|
Kevin Michael O'Neill CEO, PDx |
SELL
Payment of exercise price or tax liability
|
Direct |
763
-2.81%
|
$57,225
$75.04 P/Share
|
|
Mar 02
2023
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-2.07%
|
$40,575
$75.04 P/Share
|
|
Mar 01
2023
|
Jan Makela CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
3,489
-4.68%
|
$261,675
$75.3 P/Share
|
|
Mar 01
2023
|
Jan Makela CEO, Imaging |
BUY
Grant, award, or other acquisition
|
Direct |
9,130
+10.92%
|
-
|
|
Mar 01
2023
|
George A. Newcomb Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
369
-4.19%
|
$27,675
$75.3 P/Share
|
|
Mar 01
2023
|
George A. Newcomb Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,328
+13.11%
|
-
|
|
Mar 01
2023
|
Taha Kass Hout Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,284
+15.22%
|
-
|
|
Mar 01
2023
|
Thomas J. Westrick CEO, Patient Care Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,039
-5.72%
|
$77,925
$75.3 P/Share
|
|
Mar 01
2023
|
Thomas J. Westrick CEO, Patient Care Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
3,652
+16.74%
|
-
|
|
Mar 01
2023
|
Kevin Michael O'Neill CEO, PDx |
SELL
Payment of exercise price or tax liability
|
Direct |
1,309
-4.6%
|
$98,175
$75.3 P/Share
|
|
Mar 01
2023
|
Kevin Michael O'Neill CEO, PDx |
BUY
Grant, award, or other acquisition
|
Direct |
3,652
+11.38%
|
-
|
|
Mar 01
2023
|
Betty D Larson Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,300
+11.82%
|
-
|
|
Mar 01
2023
|
Peter J Arduini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
39,425
+32.67%
|
-
|